<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02306863</url>
  </required_header>
  <id_info>
    <org_study_id>4291</org_study_id>
    <nct_id>NCT02306863</nct_id>
  </id_info>
  <brief_title>Whole-body Vibration as a Treatment for Parkinson's Disease</brief_title>
  <official_title>The Efficacy of Long-term Whole-body Vibration in the Treatment of Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Life Financial Movement Disorders Research and Rehabilitation Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Life Financial Movement Disorders Research and Rehabilitation Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate whether whole-body vibration applied over a 12-week period is
      effective in treating motor symptoms of Parkinson's disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Parkinson's disease (PD) is a progressive neurodegenerative disease resulting in the loss of
      dopaminergic neurons projecting from the substantia nigra pars compacta to the striatum.

      Whole-body vibration (WBV) is potentially beneficial in treating Parkinson's disease because
      it has been shown to elicit effects specific to both the brain and muscular system. Animal
      models of PD indicate that whole-body vibration can increase striatal dopamine levels, as
      well as the number of dopaminergic neurons in the substantia nigra. These findings were
      correlated with increased levels of brain-derived neurotrophic factor.

      In addition to the potentially neuroplastic effects, &gt;20 Hz WBV has been shown to improve
      muscular performance. Improved muscular performance is believed to be attributed to WBV
      induced neuromuscular effects rather than muscle hypertrophy, with the specific mechanism
      defined as the tonic vibration reflex.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Unified Parkinson's Disease Rating Scale (UPDRS) section III</measure>
    <time_frame>change from baseline, 12 weeks, and 2 week washout</time_frame>
    <description>clinician monitored motor evaluation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gait Assessment</measure>
    <time_frame>change from baseline, 12 weeks, and 2 week washout</time_frame>
    <description>pressure sensitive carpet (GAITRite) measuring gait parameters (step length, step velocity, stride-to-stride variability, etc)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Timed Up &amp; Go (TUG) Test</measure>
    <time_frame>change from baseline, 12 weeks, and 2 week washout</time_frame>
    <description>measuring time participants take to stand up from chair, walk towards an obstacle, turn around, walk back to chair, and sit back down again</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Timed Grooved Pegboard Task</measure>
    <time_frame>change from baseline, 12 weeks, and 2 week washout</time_frame>
    <description>25 pegs with a key along one side must be rotated to properly be inserted into slot on board (measuring time-in and time-out)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Idiopathic Parkinson's Disease</condition>
  <condition>Primary Parkinsonism</condition>
  <arm_group>
    <arm_group_label>whole-body vibration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>40 Hz Whole-body vibration applied via physioaccoustic method for 12 weeks, 3 times a week</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham treatment</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>simulated whole-body vibration applied 3 times a week for 12 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>vibrating chair</intervention_name>
    <description>vibration provided via physioacoustic method</description>
    <arm_group_label>whole-body vibration</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham treatment</intervention_name>
    <description>simulated whole-body vibration</description>
    <arm_group_label>sham treatment</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with idiopathic Parkinson's Disease by a Neurologist

          -  Currently taking anti-Parkinsonian medication

          -  Able to stand for 2 minutes without assistance

          -  Able to walk 10 meters without assistance

          -  Ability to understand English instructions

          -  Normal or corrected vision

        Exclusion Criteria:

          -  A neurological disease other than PD

          -  recent stroke

          -  cardiovascular disease

          -  previous major hemorrhage

          -  artificial pacemaker

          -  currently pregnant

          -  Current participation in any physical therapy or experimental treatments

          -  Peripheral neuropathy, severe osteoporosis

          -  Visual impairments that cannot be corrected

          -  Clinically diagnosed with dementia

          -  Greater than mild dementia (screened using Montreal Cognitive Assessment (MOCA) &lt;24
             being excluded)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam K Koebel, BSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wilfrid Laurier University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adam K Koebel, BSc</last_name>
    <phone>519-884-0710</phone>
    <phone_ext>3924</phone_ext>
    <email>koeb2420@mylaurier.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patricia Freeman</last_name>
    <phone>519-884-0710</phone>
    <phone_ext>2877</phone_ext>
    <email>pafreeman@wlu.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sun Life Financial Movement Disorders Research &amp; Rehabilitation Centre</name>
      <address>
        <city>Waterloo</city>
        <state>Ontario</state>
        <zip>N2L 3J5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Freeman</last_name>
      <phone>519-884-0710</phone>
      <phone_ext>3924</phone_ext>
      <email>pafreeman@wlu.ca</email>
    </contact>
    <contact_backup>
      <last_name>Adam Koebel</last_name>
      <phone>519-884-0710</phone>
      <email>koeb2420@mylaurier.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Adam Koebel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Haas CT, Turbanski S, Kessler K, Schmidtbleicher D. The effects of random whole-body-vibration on motor symptoms in Parkinson's disease. NeuroRehabilitation. 2006;21(1):29-36.</citation>
    <PMID>16720935</PMID>
  </reference>
  <reference>
    <citation>Ebersbach G, Edler D, Kaufhold O, Wissel J. Whole body vibration versus conventional physiotherapy to improve balance and gait in Parkinson's disease. Arch Phys Med Rehabil. 2008 Mar;89(3):399-403. doi: 10.1016/j.apmr.2007.09.031.</citation>
    <PMID>18295614</PMID>
  </reference>
  <reference>
    <citation>King LK, Almeida QJ, Ahonen H. Short-term effects of vibration therapy on motor impairments in Parkinson's disease. NeuroRehabilitation. 2009;25(4):297-306. doi: 10.3233/NRE-2009-0528.</citation>
    <PMID>20037223</PMID>
  </reference>
  <verification_date>February 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2014</study_first_submitted>
  <study_first_submitted_qc>December 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 3, 2014</study_first_posted>
  <last_update_submitted>February 13, 2015</last_update_submitted>
  <last_update_submitted_qc>February 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Life Financial Movement Disorders Research and Rehabilitation Centre</investigator_affiliation>
    <investigator_full_name>Adam Koebel</investigator_full_name>
    <investigator_title>Undergraduate Thesis Student</investigator_title>
  </responsible_party>
  <keyword>Parkinson's Disease</keyword>
  <keyword>whole-body vibration</keyword>
  <keyword>WBV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Parkinsonian Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

